|
|
Reference
|
|
|
Adams, A.D., Hild-Petito, S., Donnelly, K., Fazleabas, A.T. (1993) Regulation of estrogen (E) and progestin (p) receptors (R) in leiomyomas during the cycle and leuprolide acetate treatment. u: Proceedings of the Forty-Ninth Annual Meeting of the American Fertility Society, Montreal, Quebec, Montreal: American Fertility Society, str. 11-14
|
|
 
|
Andersen, J., Grine, E., Eng, C.L., Zhao, K., Barbieri, R.L., Chumas, J.C., Brink, P.R. (1993) Expression of connexin-43 in human myometrium and leiomyoma. American journal of obstetrics and gynecology, 169(5): 1266-76
|
|
|
Brandon, D.D., Bethea, C.L., Strawn, E.Y., Novy, M.J., Burry, K.A., Harrington, M.S., Erickson, T.E., Warner, C., Keenan, E.J., Clinton, G.M. (1993) Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. American journal of obstetrics and gynecology, 169(1): 78-85
|
|
|
Degligdish, L., Loewenthal, M. (1970) Endometrial changes associated with myomata of the uterus. J. Clin. Pathol., 23, 677-680
|
|
|
Ferenczy, A., Bertrand, G., Gelfand, M.M. (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. American journal of obstetrics and gynecology, 133(8): 859-67
|
|
|
Harrison-Woolrych, M.L., Charnock-Jones, D.S., Smith, S.K. (1994) Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction. Journal of clinical endocrinology and metabolism, 78(5): 1179-84
|
|
|
Hofmann, G.E., Rao, C.V., Barrows, G.H. (1984) Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J. Clin. Endocrinol. Metab, 50, 880-884
|
|
3
|
Jones, M.L. (2002) Connective tissue and stains. u: Bancroft J.D., Gamble M. (ur.) Theory and practice of histological techniques, London: Churchill Livingstone
|
|
|
Kawaguchi, K., Fujii, S., Konishi, I., Nanbu, Y., Nonogaki, H., Mori, T. (1989) Mitotic activity in uterine leiomyomas during the menstrual cycle. American journal of obstetrics and gynecology, 160(3): 637-41
|
|
|
Martin, C.E.B., Brum, I.S., Stoll, J., Capp, E., Corleta, H.E. (2004) Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma. Gynecologic and obstetric investigation, 57(4): 210-3
|
|
|
Matsuo, H., Gao, H., Wang, Y. (2001) Up regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in humane uterine leiomyoma cells. Journal of Clinical Endocrinology & Metabolism, 86(11): 5593
|
|
|
Nicolle, M., Gillerot, S., Casanas-Roux, F., Squifflet, J., Berliere, M., Donnez, J. (1999) Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-realising hormone agonist therapy. Human Reproduction, 14(11): 2844
|
|
|
OConnor, D.M., Novris, H.J. (1998) Clinical-pathological study of uterine leiomyomas with high mitotic activity. Acta Obstet. Gynecol. Scand, 77, 74-77
|
|
|
Otubu, J.A., Buttram, V.C., Besch, N.F., Besch, P.K. (1982) Unconjugated steroids in leiomyomas and tumor-bearing myometrium. American journal of obstetrics and gynecology, 143(2): 130-3
|
|
|
Perrone, T., Dehner, L.P. (1988) Prognostically favorable 'mitotically active' smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases. American journal of surgical pathology, 12(1): 1-8
|
|
|
Prayson, R.A., Hart, W.R. (1992) Mitotically active leiomyomas of the uterus. American journal of clinical pathology, 97(1): 14-20
|
|
|
Rein, M.S., Friedman, A.J., Stuart, J.M., MacLaughlin, D.T. (1990) Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertility and sterility, 53(6): 1018-23
|
|
|
Savitskii, G.A. (1991) Local hyperestradiolemia of the uterus in the pathogenesis of hyperplastic endometrial processes. Vopr. Onkol, 37 (2), 179-184
|
|
|
Segaloff, A., Weed, J.C., Stenberg, W.H., Parson, W. (1949) The progesterone therapy of human uterine leiomyomas. Journal of Clinical Endocrinology & Metabolism, 9(12): 1273
|
|
|
Stewart, E.A., Friedman, A.J., Peck, K., Nowak, R.A. (1994) Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. Journal of clinical endocrinology and metabolism, 79(3): 900-6
|
|
|
Tiltman, A.J. (1985) The effect of progestins on the mitotic activity of uterine fibromyomas. International Journal of Gynecological Pathology, 4(2): 89
|
|
1
|
Vukovic, I., Arsenijevic, N., Lackovic, V., Todorovic, V. (2006) The origin and differentiation potential of smooth muscle cells in coronary atherosclerosis. Exp. Clin. Cardiol, 11 (2), 35-41
|
|
2
|
Vuković, I., Lačković, V., Todorović, V., Kanjuh, V., Ilić, S. (2004) Citohistološke i imunohistohemijske odlike intime i medije aorte u koarktaciji adultnog tipa. Srpski arhiv za celokupno lekarstvo, 132(1): 66-71
|
|
|
Yamamoto, T., Takamori, K., Okada, H. (1984) Estrogen biosynthesis in leiomyoma and myometrium of the uterus. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme, 16(12): 678-9
|
|
|
Yeh, J., Rein, M., Nowak, R. (1991) Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata. Fertility and sterility, 56(5): 997-1000
|
|
|
Zaouldek, C.J., Norris, H.J. (1981) Mesenchimal tumors of the uterus. Prog. Surg. Pathol, 3, 1-35
|
|
|
|
|